Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

NCT00851721 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A or B With Inhibitors
Hemophilia A
Hemophilia B

Interventions

BIOLOGICAL: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
BIOLOGICAL: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)

Sponsor

Baxalta now part of Shire